Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation

NCT05206318 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hyperpigmentation; Postinflammatory

Interventions

DRUG: Topical Cysteamine
DRUG: Topical Vehicle Control

Sponsor

Chang Gung Memorial Hospital

Collaborators

[object Object]